A
Proximagen Robin Turner
B
www.proximagen.com Tel: 01223 497300
C D E
Fax: 01223 496083
The company’s founders originate from a Pfizer Global Research & Development drug discovery team in what had previously been the Parke-Davis Neuroscience Research Centre. The founders, together with some key academic collaborators, created the company to exploit several opportunities in drug discovery as well as their world class “gene to lead” drug discovery capability. The company has well equipped modern laboratory and office facilities situated on the Babraham Research Campus. This location allows the company to forge links with a host of world class research groups based in the Cambridge area.
Minerva Building (250), Babraham Research Campus, Babraham, Cambridge, Cambridgeshire CB22 3AT
F G H I J K
Psynova Neurotech Barbara Baron barbara.baron@psynova.com www.psynova-neurotech.com Tel: 01223 421635
Psynova Neurotech is exclusively focused on the commercial development and exploitation of novel biomarkers for Neuropsychiatric and other mental illnesses. Building on 12 years of ground-breaking research by its founder Prof. Sabine Bahn, Psynova Neurotech is initially concentrating on Schizophrenia and Bipolar Affective Disorder. In 2010, our first product was launched in the USA by our partner Rules Based Medicine, Inc.; VeriPsych™ is the first and only blood test to aid a psychiatrist in the diagnosis of recent-onset schizophrenia.
St John’s Innovation Centre, Cowley Road, Cambridge CB4 0WS
L M N O
Quotient Bioresearch Ltd info@quotientbioresearch.com www.quotientbioresearch.com
P
Tel: 01638 720500
Q
Newmarket Road, Fordham, Cambridge CB7 5WW
R
Fax: 01638 724200
Quotient Bioresearch provides specialist laboratory and clinical services focused on early phase drug development from discovery through to proof of concept. - Integrated preclinical and clinical DMPK with GMP chemistry/radiosynthesis - Bioanalytical sciences from the world’s leading sports drug surveillance laboratory Comprehensive microbiology for discovery and development of antimicrobials - Formulation development, GMP manufacturing and GCP Phase I clinic in the same facility With over 350 highly skilled scientists and facilities in Cambridgeshire, Northamptonshire, Nottingham, Edinburgh and Cardiff, Quotient Bioresearch has comprehensive capabilities and is the only drug development partner which provides a truly integrated service from discovery to proof of concept. This is demonstrated in our unique Synthesis-to-Clinic™ service providing carbon-14 labelled compounds through to pre-clinical metabolism studies and integrated 14C clinical programmes, supported by our purpose built bioanalytical and central laboratory facilities.
S T U
Recombinant Antibody Technology Ltd Tel: 01223 497171
V W X Y Z 78
One Nucleus Directory 2011
Recombinant Antibody Technology Ltd. is specializing in the generation of large recombinant DNA constructs using YAC and BAC technologies. Currently, the company is working with Open Monoclonal Technology, Inc., a US based biotechnology company, on the generation of recombinant immunoglobulin loci for the generation of genetically engineered rats expressing antibodies with fully human idiotypes.